147 results on '"Colaianni G"'
Search Results
2. Irisina, osso e muscolo
- Author
-
Colaianni, G., Mongelli, T., Colucci, S., Cinti, S., and Grano, M.
- Published
- 2016
- Full Text
- View/download PDF
3. The Oxytocin–Bone Axis
- Author
-
Colaianni, G., Tamma, R., Di Benedetto, A., Yuen, T., Sun, L., Zaidi, M., and Zallone, A.
- Published
- 2014
- Full Text
- View/download PDF
4. Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells
- Author
-
Ballini, A., Di Benedetto, A., Vito, D., Scarano, A., Scacco, S., Perillo, L., Posa, F., Dipalma, G., Paduano, F., Maria Contaldo, Grano, M., Brunetti, G., Colaianni, G., Di Cosola, M., Cantore, S., Mori, G., Ballini, A., Di Benedetto, A., De Vito, D., Scarano, A., Scacco, S., Perillo, L., Posa, F., Di Palma, G., Paduano, F., Contaldo, M., Grano, M., Brunetti, G., Colaianni, G., Di Cosola, M., Cantore, S., and Mori, G.
- Subjects
Male ,Gene Expression ,Cell Differentiation ,Mesenchymal Stem Cells ,Kruppel-Like Factor 4 ,Osteogenesis ,Dental bud ,Tissue regeneration ,Humans ,Female ,Oral and maxillofacial surgery ,Child ,Cells, Cultured ,Dental Pulp ,Mesenchymal stem cell ,Stemness gene - Abstract
OBJECTIVE: Mesenchymal stem cells (MSCs) have been deeply investigated in regenerative medicine because of their crucial role in tissue healing, such as tissue regeneration. Dental-derived stem cells (d-DSCs) are easily available from dental tissues, which can be isolated from all age patients with minimal discomfort. PATIENTS AND METHODS: Normal unerupted third molars tooth buds were collected from adolescents' patients underwent to extractions for orthodontic reasons. The expression of the genes Kruppel-like factor 4 (Klf-4), octamer-binding transcription factor 4 (Oct-4), homeobox transcription factor Nanog (NANOG) was investigated in d-DSCs obtained from dental bud (DBSCs), differentiated toward osteoblastic phenotype and not. RESULTS: Our results showed that DBSCs expressed Oct-4, Nanog, and Klf-4 in undifferentiated conditions and interestingly the expression of such genes increased when the cells were kept in osteogenic medium. CONCLUSIONS: These attractive stemness properties, together with the effortlessly isolation, during common oral and maxillofacial surgical procedures, from undifferentiated tissues such as dental bud, make this kind of d-DSCs a promising tool in regenerative medicine, having the potential for clinical applications, and reinforcing the present challenge to develop new preventive and healing strategies in tissue regeneration.
- Published
- 2019
5. Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases
- Author
-
Colaianni, G., primary, Storlino, G., additional, Sanesi, L., additional, Colucci, S., additional, and Grano, Maria, additional
- Published
- 2020
- Full Text
- View/download PDF
6. Pregnancy and lactation, a challenge for the skeleton
- Author
-
Winter, E M, primary, Ireland, A, additional, Butterfield, N C, additional, Haffner-Luntzer, M, additional, Horcajada, M-N, additional, Veldhuis-Vlug, A G, additional, Oei, L, additional, Colaianni, G, additional, and Bonnet, N, additional
- Published
- 2020
- Full Text
- View/download PDF
7. Decoding wood exploitation in archaeological sites in South-Eastern Italy
- Author
-
D’Oronzo, C., Colaianni, G., Grasso, A. M., Martella, D., Stellati, A., FIORENTINO, Girolamo, F. Damblon, D’Oronzo, C., Colaianni, G., Grasso, A. M., Martella, D., Stellati, A., and Fiorentino, Girolamo
- Published
- 2013
8. Irisin, the novel myokine responsible for benefits of physical exercise on bone
- Author
-
Colaianni, G., Cuscito, C., Mongelli, T., Buccoliero, C., Di Comite, and Grano, M.
- Subjects
Irisin ,physical activity ,osteoblast ,osteopenia ,sarcopenia - Abstract
It has been recently reported that, after physical exercise activity, the skeletal muscle releases Irisin, the newly identified myokine able of driving transition of white adipocytes into brown, following a phenomenon known as the browning response. This result suggested that skeletal muscle is crucial in the regulation of energy homeostasis, supporting its role as endocrine organ that targets adipose tissue by promoting energy expenditure. In accordance with this new finding, we demonstrated that conditioned media (CM) collected from primary myoblasts of exercised mice were able to induce osteoblast differentiation in a greater extent than those of mice housed in resting conditions and this effect is Irisin-mediated. In view of further proving the involvement of Irisin in bone metabolism, we validate its direct effect on osteoblasts by using r-Irisin. Here we show that phosphorylation of MAP kinase ERK and expression of Atf 4 (p, Italian Journal of Anatomy and Embryology, Vol 119, No 1 (Supplement) 2014
- Published
- 2015
- Full Text
- View/download PDF
9. Decoding wood exploitation in archaeological site by taphonomical analysis
- Author
-
D'Oronzo, Cosimo, Colaianni, G., Grasso, A. M., Martella, D., Stellati, A., and Fiorentino, G.
- Published
- 2013
10. Lo scavo microstratigrafico delle 'Canalette' dell'area orientale del villaggio
- Author
-
Fiorentino, G., Colaianni, G., and D'Oronzo, Cosimo
- Published
- 2010
11. Decoding wood exploitation in archaeological site by taphonomic analysis
- Author
-
D'Oronzo, Cosimo, Colaianni, G., Grasso, A. M., Martella, D., Stellati, A., and Fiorentino, G.
- Published
- 2008
12. Archaeobotanical analysis at Tas-Silg sanctuary (Malta island) from Tarxien Cemetery phase to Phoenician period
- Author
-
Colaianni, G., D'Oronzo, Cosimo, and Fiorentino, G.
- Published
- 2007
13. Lecce, ex Convento del Carmine. Un’associazione di reperti ceramici, vitrei, faunistici e botanici in un silo del XIV secolo
- Author
-
Caprino, P., Colaianni, G., Girolamo FIORENTINO, Paolo Gull, Portulano, C., M, Solinas A., Tagliente, P., Caprino, Patricia, Colaianni, Giampiero, Fiorentino, Girolamo, Gull, Paolo, Portulano, C, SOLINAS A., M, and Tagliente, P.
- Published
- 2007
14. How to Reach Emotions with Psychosomatic Patients: A Case Report
- Author
-
Colaianni, G, primary and Poot, F, additional
- Published
- 2014
- Full Text
- View/download PDF
15. Effects of Arg-vasopressin on osteoblasts
- Author
-
Tamma⁎, R., primary, di Benedetto, A., additional, Colaianni, G., additional, Cuscito, C., additional, Dell'Endice, S., additional, Greco, G., additional, Corcelli, M., additional, and Zallone, A., additional
- Published
- 2011
- Full Text
- View/download PDF
16. Oxytocin receptor nuclear translocation mediates upregulation of osteoblast specific genes
- Author
-
Di Benedetto, A., primary, Dell' Endice, S., additional, Colaianni, G., additional, Tamma, R., additional, Zambonin, C., additional, Calvano, D., additional, Chini, B., additional, Nico, B., additional, Malavasi, F., additional, and Zallone, A., additional
- Published
- 2011
- Full Text
- View/download PDF
17. Direct or oxytocin - mediated estrogen actions on bone
- Author
-
Colaianni⁎, G., primary, Cuscito, C., additional, Di Benedetto, A., additional, Tamma, R., additional, Greco, G., additional, Dell'Endice, S., additional, Sun, L., additional, Bab, I., additional, Zaidi, M., additional, and Zallone, A., additional
- Published
- 2010
- Full Text
- View/download PDF
18. Oxytocin receptors translocate into osteoblast nucleus where interact with transcription factors
- Author
-
Di Benedetto⁎, A., primary, Dell'Endice, S., additional, Cuscito, C., additional, Colaianni, G., additional, Tamma, R., additional, Chini, B., additional, and Zallone, A., additional
- Published
- 2010
- Full Text
- View/download PDF
19. Inhibition of bone resorption by oxytocin is due to an increase of expression and activity of no synthase
- Author
-
Colaianni⁎, G., primary, Di Benedetto, A., additional, Tamma, R., additional, Montemurro, G., additional, Greco, G., additional, Vergari, R., additional, Grano, A., additional, Dell'Endice, S., additional, Mancini, L., additional, and Zallone, A., additional
- Published
- 2009
- Full Text
- View/download PDF
20. 92 In Vitro Osteoclastogenesis and Bone Resorption During Spaceflight
- Author
-
Tamma, R., primary, Colaianni, G., additional, Camerino, C., additional, Di Benedetto, A., additional, Greco, G., additional, Strippoli, M., additional, Vergari, R., additional, Grano, A., additional, Mancini, L., additional, and Zallone, A., additional
- Published
- 2009
- Full Text
- View/download PDF
21. Synovial Fluid Fibroblasts and Lymphocytes Support the Osteoclastogenesis in Human Psoriatic Arthritis
- Author
-
MORI, G., primary, CANTATORE, F. P., additional, BRUNETTI, G., additional, ORANGER, A., additional, COLAIANNI, G., additional, QUARTA, L., additional, CORRADO, A., additional, COLUCCI, S., additional, and GRANO, M., additional
- Published
- 2007
- Full Text
- View/download PDF
22. Oxytocin: An estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption
- Author
-
Colaianni, G., Tamma, R., Di Benedetto, A., Patano, N., Camerino, C., Li, S., Zaidi, M., and Zallone, A.
- Published
- 2006
- Full Text
- View/download PDF
23. HUMAN-ENVIRONMENTAL INTERACTION IN MALTA FROM THE NEOLITHIC TO THE ROMAN PERIOD: ARCHAEOBOTANICAL ANALYSES AT TAS-SILĠ
- Author
-
Girolamo FIORENTINO, D’oronzo, C., Colaianni, G., Fiorentino, Girolamo, C., D’Oronzo, and Colaianni, Giampiero
24. In vitro osteoclastogenesis and bone resorption are increased during spaceflight
- Author
-
Di Benedetto, A., Camerino, C., Roberto TAMMA, Colaianni, G., Greco, G., Strippoli, M., Vergari, R., Grano, A., and Zallone, A.
25. Mitochondrial F0 F1 H+ -ATPase:Characterization of F0 components involved in H+ translocation
- Author
-
Guerrieri, F., primary, Capozza, G., additional, Houštěk, J., additional, Zanotti, F., additional, Colaianni, G., additional, Jirillo, E., additional, and Papa, S., additional
- Published
- 1989
- Full Text
- View/download PDF
26. Mitochondrial F0F1H+‐ATPase:Characterization of F0components involved in H+translocation
- Author
-
Guerrieri, F., Capozza, G., Houštěk, J., Zanotti, F., Colaianni, G., Jirillo, E., and Papa, S.
- Published
- 1989
- Full Text
- View/download PDF
27. Mitochondrial F 0F 1H +-ATPase:Characterization of F 0components involved in H +translocation
- Author
-
Guerrieri, F., Capozza, G., Houštěk, J., Zanotti, F., Colaianni, G., Jirillo, E., and Papa, S.
- Published
- 1989
- Full Text
- View/download PDF
28. Oxytocin receptors translocate into osteoblast nucleus where interact with transcription factors
- Author
-
⁎, A., Dell'Endice, S., Cuscito, C., Colaianni, G., Tamma, R., Chini, B., and Zallone, A.
- Published
- 2010
- Full Text
- View/download PDF
29. Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease.
- Author
-
Dicarlo M, Pignataro P, Zecca C, Dell'Abate MT, Urso D, Gnoni V, Giugno A, Borlizzi F, Zerlotin R, Oranger A, Colaianni G, Colucci S, Logroscino G, and Grano M
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Cognitive Dysfunction cerebrospinal fluid, Cognitive Dysfunction blood, Cognitive Dysfunction diagnosis, Aged, 80 and over, Cohort Studies, Alzheimer Disease cerebrospinal fluid, Alzheimer Disease blood, Alzheimer Disease diagnosis, Fibronectins cerebrospinal fluid, Fibronectins blood, Biomarkers cerebrospinal fluid, Biomarkers blood, Amyloid beta-Peptides cerebrospinal fluid, Amyloid beta-Peptides blood, tau Proteins cerebrospinal fluid, tau Proteins blood, Peptide Fragments cerebrospinal fluid, Peptide Fragments blood
- Abstract
Objective: Irisin, released by muscles during exercise, was recently identified as a neuroprotective factor in mouse models of Alzheimer disease (AD). In a cohort of AD patients, we studied cerebrospinal fluid (CSF) and plasma irisin levels, sex interactions, and correlations with disease biomarkers., Methods: Correlations between CSF and plasma irisin levels and AD biomarkers (amyloid β 1-42, hyperphosphorylated tau, and total tau [t-tau]) and Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) were analyzed in a cohort of patients with Alzheimer dementia (n = 82), mild cognitive impairment (n = 44), and subjective memory complaint (n = 20) biologically characterized according to the recent amyloid/tau/neurodegeneration classification., Results: CSF irisin was reduced in Alzheimer dementia patients (p < 0.0001), with lower levels in female patients. Moreover, CSF irisin correlated positively with Aβ42 in both female (r = 0.379, p < 0.001) and male (r = 0.262, p < 0.05) patients, and negatively with CDR-SOB (r = -0.234, p < 0.05) only in female patients. A negative trend was also observed between CSF irisin and t-tau levels in all patients (r = -0.144, p = 0.082) and in the female subgroup (r = -0.189, p = 0.084)., Interpretation: The results highlight the relationship between irisin and biomarkers of AD pathology, especially in females. Our findings also offer perspectives toward the use of irisin as a marker of the AD continuum. ANN NEUROL 2024;96:61-73., (© 2024 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)
- Published
- 2024
- Full Text
- View/download PDF
30. Multiscale and multidisciplinary analysis of aging processes in bone.
- Author
-
Ravazzano L, Colaianni G, Tarakanova A, Xiao YB, Grano M, and Libonati F
- Abstract
The world population is increasingly aging, deeply affecting our society by challenging our healthcare systems and presenting an economic burden, thus turning the spotlight on aging-related diseases: exempli gratia, osteoporosis, a silent disease until you suddenly break a bone. The increase in bone fracture risk with age is generally associated with a loss of bone mass and an alteration in the skeletal architecture. However, such changes cannot fully explain increased fragility with age. To successfully tackle age-related bone diseases, it is paramount to comprehensively understand the fundamental mechanisms responsible for tissue degeneration. Aging mechanisms persist at multiple length scales within the complex hierarchical bone structure, raising the need for a multiscale and multidisciplinary approach to resolve them. This paper aims to provide an overarching analysis of aging processes in bone and to review the most prominent outcomes of bone aging. A systematic description of different length scales, highlighting the corresponding techniques adopted at each scale and motivating the need for combining diverse techniques, is provided to get a comprehensive description of the multi-physics phenomena involved., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
31. Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma.
- Author
-
Zerlotin R, Oranger A, Pignataro P, Dicarlo M, Sanesi L, Suriano C, Storlino G, Rizzi R, Mestice A, Di Gioia S, Mori G, Grano M, Colaianni G, and Colucci S
- Abstract
Bone disease associated with multiple myeloma (MM) is characterized by osteolytic lesions and pathological fractures, which remain a therapeutic priority despite new drugs improving MM patient survival. Antiresorptive molecules represent the main option for the treatment of MM-associated bone disease (MMBD), whereas osteoanabolic molecules are under investigation. Among these latter, we here focused on the myokine irisin, which is able to enhance bone mass in healthy mice, prevent bone loss in osteoporotic mouse models, and accelerate fracture healing in mice. Therefore, we investigated irisin effect on MMBD in a mouse model of MM induced by intratibial injection of myeloma cells followed by weekly administration of 100 μg/kg of recombinant irisin for 5 wk. By micro-Ct analysis, we demonstrated that irisin improves MM-induced trabecular bone damage by partially preventing the reduction of femur Trabecular Bone Volume/Total Volume ( P = .0028), Trabecular Number ( P = .0076), Trabecular Fractal Dimension ( P = .0044), and increasing Trabecular Separation ( P = .0003) in MM mice. In cortical bone, irisin downregulates the expression of Sclerostin, a bone formation inhibitor, and RankL, a pro-osteoclastogenic molecule, while in BM it upregulates Opg, an anti-osteoclastogenic cytokine. We found that in the BM tibia of irisin-treated MM mice, the percentage of MM cells displays a reduction trend, while in the femur it decreases significantly. This is in line with the in vitro reduction of myeloma cell viability after 48 h of irisin stimulation at both 200 and 500 ng/mL and, after 72 h already at 100 ng/mL rec-irisin. These results could be due to irisin ability to downregulate the expression of Notch 3, which is important for cell-to-cell communication in the tumor niche, and Cyclin D1, supporting an inhibitory effect of irisin on MM cell proliferation. Overall, our findings suggest that irisin could be a new promising strategy to counteract MMBD and tumor burden in one shot., Competing Interests: All the authors declare that there is no conflict of interest regarding the publication of this work. All authors read and approved the final version of the submitted manuscript and consent to be responsible for all aspects of the research. They ensure that all questions related to the integrity or accuracy of the research are properly explored and solved., (© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.)
- Published
- 2024
- Full Text
- View/download PDF
32. LIGHT/TNFSF14 Affects Adipose Tissue Phenotype.
- Author
-
Oranger A, Colaianni G, Ingravallo G, Scarcella VS, Faienza MF, Grano M, Colucci S, and Brunetti G
- Subjects
- Animals, Mice, Adipocytes, Brown, Genotype, Phenotype, Uncoupling Protein 1 genetics, Adipose Tissue, Adipose Tissue, White
- Abstract
LIGHT/TNFSF14 is linked to several signaling pathways as a crucial member of a larger immunoregulatory network. It is primarily expressed in inflammatory effector cells, and high levels of LIGHT have been reported in obesity. Thus, with the aim of deepening the knowledge of the role of LIGHT on adipose tissue phenotype, we studied wild-type (WT), Tnfsf14
- / - , Rag-/- and Rag -/ Tnfsf14 - (DKO) mice fed a normal diet (ND) or high-fat diet (HFD). Our results show that, although there is no significant weight gain between the mice with different genotypes, it is significant within each of them. We also detected an increase in visceral White Adipose Tissue (vWAT) weight in all mice fed HFD, together with the lowest levels of vWAT weight in Tnfsf14-/- and DKO mice fed ND with respect to the other strain. Inguinal WAT (iWAT) weight is significantly affected by genotype and HFD. The least amount of iWAT was detected in DKO mice fed ND. Histological analysis of vWAT showed that both the genotype and the diet significantly affect the adipocyte area, whereas the number is affected only by the genotype. In iWAT, the genotype and the diet significantly affect mean adipocyte area and number; interestingly, the area with the least adipocyte was detected in DKO mice fed ND, suggesting a potential browning effect due to the simultaneous lack of mature lymphocytes and LIGHT. Consistently, Uncoupling Protein 1 (UCP1) staining of iWAT demonstrated that few positive brown adipocytes appeared in DKO mice. Furthermore, LIGHT deficiency is associated with greater levels of UCP1, highlighting the lack of its expression in Rag-/- mice. Liver examination showed that all mice fed HFD had a steatotic liver, but it was particularly evident for DKO mice. In conclusion, our study demonstrates that the adipose tissue phenotype is affected by LIGHT levels but also much more by mature lymphocytes.- Published
- 2024
- Full Text
- View/download PDF
33. Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity.
- Author
-
Storlino G, Dicarlo M, Zerlotin R, Pignataro P, Sanesi L, Suriano C, Oranger A, Mori G, Passeri G, Colucci S, Grano M, and Colaianni G
- Subjects
- Mice, Animals, Female, Humans, Fibronectins pharmacology, Cancellous Bone pathology, Disease Models, Animal, Osteoblasts pathology, Ovariectomy adverse effects, Bone Density, Osteoporosis pathology, Bone Diseases, Metabolic
- Abstract
Irisin is a peptide secreted by skeletal muscle that plays a major role in bone metabolism. Experiments in mouse models have shown that administration of recombinant irisin prevents disuse-induced bone loss. In this study, we aimed to evaluate the effects of irisin treatment for the prevention of bone loss in the ovariectomized (Ovx) mouse, the animal model commonly used to investigate osteoporosis caused by estrogen deficiency. Micro-Ct analysis conducted on Sham mice (Sham-veh) and Ovx mice treated with vehicle (Ovx-veh) or recombinant irisin (Ovx-irisn) showed bone volume fraction (BV/TV) decreases in femurs (Ovx-veh 1.39± 0.71 vs. Sham-veh 2.84 ± 1.23; p = 0.02) and tibia at both proximal condyles (Ovx-veh 1.97 ± 0.68 vs. Sham-veh 3.48 ± 1.26; p = 0.03) and the subchondral plate (Ovx-veh 6.33 ± 0.36 vs. Sham-veh 8.18 ± 0.41; p = 0.01), which were prevented by treatment with a weekly dose of irisin for 4 weeks. Moreover, histological analysis of trabecular bone showed that irisin increased the number of active osteoblasts per bone perimeter (Ovx-irisin 32.3 ± 3.9 vs. Ovx-veh 23.5 ± 3.6; p = 0.01), while decreasing osteoclasts (Ovx-irisin 7.6 ± 2.4 vs. Ovx-veh 12.9 ± 3.04; p = 0.05). The possible mechanism by which irisin enhances osteoblast activity in Ovx mice is upregulation of the transcription factor Atf4 , one of the key markers of osteoblast differentiation, and osteoprotegerin, thereby inhibiting osteoclast formation.
- Published
- 2023
- Full Text
- View/download PDF
34. Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice.
- Author
-
Dicarlo M, Pignataro P, Zerlotin R, Suriano C, Zecca C, Dell'Abate MT, Storlino G, Oranger A, Sanesi L, Mori G, Grano M, Colaianni G, and Colucci S
- Subjects
- Mice, Female, Male, Animals, Hippocampus metabolism, Prefrontal Cortex metabolism, RNA, Messenger metabolism, Brain-Derived Neurotrophic Factor metabolism, Antidepressive Agents pharmacology
- Abstract
As a result of physical exercise, muscle releases multiple exerkines, such as "irisin", which is thought to induce pro-cognitive and antidepressant effects. We recently demonstrated in young healthy mice the mitigation of depressive behaviors induced by consecutive 5 day irisin administration. To understand which molecular mechanisms might be involved in such effect, we here studied, in a group of mice previously submitted to a behavioral test of depression, the gene expression of neurotrophins and cytokines in the hippocampus and prefrontal cortex (PFC), two brain areas frequently investigated in the depression pathogenesis. We found significantly increased mRNA levels of nerve growth factor (NGF) and fibroblast growth factor 2 (FGF-2) in the hippocampus and brain-derived growth factor (BDNF) in the PFC. We did not detect a difference in the mRNA levels of interleukin 6 (IL-6) and IL-1β in both brain regions. Except for BDNF in the PFC, two-way ANOVA analysis did not reveal sex differences in the expression of the tested genes. Overall, our data evidenced a site-specific cerebral modulation of neurotrophins induced by irisin treatment in the hippocampus and the PFC, contributing to the search for new antidepressant treatments targeted at single depressive events with short-term protocols.
- Published
- 2023
- Full Text
- View/download PDF
35. Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice.
- Author
-
Pignataro P, Dicarlo M, Suriano C, Sanesi L, Zerlotin R, Storlino G, Oranger A, Zecca C, Dell'Abate MT, Mori G, Grano M, Colucci S, and Colaianni G
- Subjects
- Mice, Male, Female, Animals, Fibronectins metabolism, Anxiety drug therapy, Antidepressive Agents pharmacology, Behavior, Animal, Depression drug therapy, Depression metabolism, Anti-Anxiety Agents pharmacology
- Abstract
Major depression is one of the most common psychiatric disorders worldwide, usually associated with anxiety. The multi-etiological nature of depression has increased the search for new antidepressant molecules, including irisin, for which, in a previous study, we tested its effect in young mice when administered intraperitoneally in a long-term intermittent manner. Here, we evaluated the effect of subcutaneous short-term irisin administration (100 µg/Kg/day/5 days) in male and female mice subjected to behavioral paradigms: Tail Suspension Test (TST), Forced Swim Test (FST), Elevated Plus Maze (EPM), and Y Maze (YM). Moreover, a qRT-PCR assay was performed to analyze the impact of irisin treatment on Pgc-1α/FNDC5 expression in the brain. A significant reduction in immobility time in TST and FST was observed in irisin-treated mice. Furthermore, irisin treatment significantly increased the number of entries and time spent in open arms, demonstrating its anxiolytic effect. Memory-enhancing effects were not reported in YM. Interestingly, no gender differences were observed in all behavioral tests. Overall, these results suggest that short-term subcutaneous irisin administration can exert an antidepressant and anxiolytic role, probably due to the activation of the Pgc-1α/FNDC5 system in the brain. Further investigation could lead to the identification of irisin as a new agent for the treatment of psychiatric disorders.
- Published
- 2023
- Full Text
- View/download PDF
36. Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle.
- Author
-
Sanesi L, Dicarlo M, Pignataro P, Zerlotin R, Pugliese F, Columbu C, Carnevale V, Tunnera S, Scillitani A, Grano M, Colaianni G, and Colucci S
- Subjects
- Humans, Female, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha metabolism, Sirtuin 1 metabolism, Muscle, Skeletal metabolism, Transcription Factors metabolism, Vitamins metabolism, Vitamin D metabolism, Fibronectins metabolism, Cholestanes
- Abstract
Irisin is a myokine synthesized by skeletal muscle, which performs key actions on whole-body metabolism. Previous studies have hypothesized a relationship between irisin and vitamin D, but the pathway has not been thoroughly investigated. The purpose of the study was to evaluate whether vitamin D supplementation affected irisin serum levels in a cohort of 19 postmenopausal women with primary hyperparathyroidism (PHPT) treated with cholecalciferol for six months. In parallel, to understand the possible link between vitamin D and irisin, we analyzed the expression of the irisin precursor, Fndc5 , in the C2C12 myoblast cell line treated with a biologically active form of vitamin D, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3). Our results demonstrate that vitamin D supplementation resulted in a significant increase in irisin serum levels ( p = 0.031) in PHPT patients. In vitro, we show that vitamin D treatment on myoblasts enhanced Fndc5 mRNA after 48 h ( p = 0.013), while it increased mRNAs of sirtuin 1 ( Sirt1 ) ( p = 0.041) and peroxisome proliferator-activated receptor γ coactivator 1α ( Pgc1α ) ( p = 0.017) over a shorter time course. Overall, our data suggest that vitamin-D-induced modulation of Fndc5/irisin occurs through up-regulation of Sirt1, which together with Pgc1α, is an important regulator of numerous metabolic processes in skeletal muscle.
- Published
- 2023
- Full Text
- View/download PDF
37. Irisin Role in Chondrocyte 3D Culture Differentiation and Its Possible Applications.
- Author
-
Posa F, Zerlotin R, Ariano A, Cosola MD, Colaianni G, Fazio AD, Colucci S, Grano M, and Mori G
- Abstract
Irisin is a recently discovered cytokine, better known as an exercise-induced myokine, produced primarily in skeletal muscle tissue as a response to exercise. Although the skeleton was initially identified as the main target of Irisin, its action is also proving effective in many other tissues. Physical activity determines a series of beneficial effects on health, including the possibility of counteracting the damage that is caused by arthritis to the cartilage of people suffering from osteoarthritis. Nevertheless, up to now, the studies that have taken into consideration the possible involvement of Irisin on the well-being of cartilage tissue are particularly limited. In this study, we postulated that the protective effect of physical activity on cartilage tissue may depend on the paracrine action of Irisin secreted during exercise; therefore, we analyzed the effects of Irisin, in vitro, on chondrogenic differentiation. To achieve this goal, three-dimensional cultures of commercially available human articular chondrocytes (HACs) were treated with the molecule under study. Our results revealed new crosstalk mechanisms between muscle and cartilage tissue. Furthermore, the confirmation of Irisin ability to induce chondrogenic differentiation could favor the development of exercise-mimetic drugs, with application relevance for patients who cannot perform physical activity.
- Published
- 2023
- Full Text
- View/download PDF
38. Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance.
- Author
-
Zerlotin R, Fornaro M, Errede M, Pignataro P, Suriano C, Ruggieri M, Colucci S, Iannone F, Grano M, and Colaianni G
- Subjects
- Humans, Fibronectins metabolism, Cohort Studies, Muscle, Skeletal metabolism, Transcription Factors metabolism, Necrosis metabolism, ADAM10 Protein genetics, ADAM10 Protein metabolism, Membrane Proteins genetics, Membrane Proteins metabolism, Amyloid Precursor Protein Secretases metabolism, Myositis metabolism, Autoimmune Diseases metabolism
- Abstract
Dermatomyositis (DM) and immune-mediated necrotizing myopathy (IMNM) are two rare diseases belonging to the group of idiopathic inflammatory myopathies (IIM). Muscle involvement in DM is characterized by perifascicular atrophy and poor myofiber necrosis, while IMNM is characterized by myofiber necrosis with scarce inflammatory infiltrates. Muscle biopsies and laboratory tests are helpful in diagnosis, but currently, few biomarkers of disease activity and progression are available. In this context, we conducted a cohort study of forty-one DM and IMNM patients, aged 40-70 years. In comparison with control subjects, in the muscle biopsies of these patients, there was a lower expression of FNDC5, the precursor of irisin, a myokine playing a key role in musculoskeletal metabolism. Expectedly, the muscle cross-sectional areas of these patients were reduced, while, surprisingly, serum irisin levels were higher than in CTRL, as were mRNA levels of ADAM10, a metalloproteinase recently shown to be the cleavage agent for FNDC5. We hypothesize that elevated expression of ADAM10 in the skeletal muscle of DM and IMNM patients might be responsible for the discrepancy between irisin levels and FNDC5 expression. Future studies will be needed to understand the mechanisms underlying exacerbated FNDC5 cleavage and muscle irisin resistance in these inflammatory myopathies.
- Published
- 2023
- Full Text
- View/download PDF
39. Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis.
- Author
-
Sanesi L, Storlino G, Dicarlo M, Oranger A, Zerlotin R, Pignataro P, Suriano C, Guida G, Grano M, Colaianni G, and Colucci SC
- Abstract
The identification of biomarkers and countermeasures to prevent the adverse effects on the musculoskeletal system caused by the absence of mechanical loading is the main goal of space biomedical research studies. In this study, we analyzed over 4 weeks of unloading, the modulation in the expression of key proteins in Vastus lateralis, Gastrocnemius and cortical bone in parallel with the modulation of irisin serum levels and its precursor FNDC5 in skeletal muscle of hind limb unloaded (HU) mice. Here we report that Atrogin-1 was up-regulated as early as 1- and 2-week of unloading, whereas Murf-1 at 2- and 3-weeks, along with a marked modulation in the expression of myosin heavy chain isoforms during unloading. Since HU mice showed reduced irisin serum levels at 4-weeks, as well as FNDC5 decrease at 3- and 4-weeks, we treated HU mice with recombinant irisin for 4 weeks, showing that unloading-dependent decline of myosin heavy chain isoforms, MyHCIIα and MyHCIIx, and the anti-apoptotic factor Bcl2, were prevented. In parallel, irisin treatment inhibited the increase of the senescence marker p53, and the pro-apoptotic factor Bax. Overall, these results suggest that the myokine irisin could be a possible therapy to counteract the musculoskeletal impairment caused by unloading., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
40. Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing.
- Author
-
Oranger A, Zerlotin R, Buccoliero C, Sanesi L, Storlino G, Schipani E, Kozloff KM, Mori G, Colaianni G, Colucci S, and Grano M
- Subjects
- Animals, Male, Mice, Fibronectins genetics, Mice, Inbred C57BL, Osteogenesis, Vascular Endothelial Growth Factor A genetics, Fracture Healing, Tibial Fractures drug therapy
- Abstract
Bone fractures are a widespread clinical event due to accidental falls and trauma or bone fragility; they also occur in association with various diseases and are common with aging. In the search for new therapeutic strategies, a crucial link between irisin and bone fractures has recently emerged. To explore this issue, we subjected 8-week-old C57BL/6 male mice to tibial fracture, and then we treated them with intra-peritoneal injection of r-Irisin (100 µg/kg/weekly) or vehicle as control. At day 10 post fracture, histological analysis showed a significant reduced expression of inflammatory cytokines as tumor necrosis factor-alpha (TNFα) ( p = 0.004) and macrophage inflammatory protein-alpha (MIP-1α) ( p = 0.015) in the cartilaginous callus of irisin-treated mice compared to controls, supporting irisin's anti-inflammatory role. We also found increased expressions of the pro-angiogenic molecule vascular endothelial growth factor (VEGF) ( p = 0.002) and the metalloproteinase MMP-13 ( p = 0.0006) in the irisin-treated mice compared to the vehicle ones, suggesting a myokine involvement in angiogenesis and cartilage matrix degradation processes. Moreover, the bone morphogenetic protein (BMP2) expression was also upregulated ( p = 0.002). Taken together, our findings suggest that irisin can contribute to fracture repair by reducing inflammation and promoting vessel invasion, matrix degradation, and bone formation, supporting its possible role as a novel molecule for fracture treatment.
- Published
- 2023
- Full Text
- View/download PDF
41. Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism.
- Author
-
Oranger A, Storlino G, Dicarlo M, Zerlotin R, Pignataro P, Sanesi L, Narici M, Pišot R, Simunič B, Colaianni G, Grano M, and Colucci S
- Subjects
- Humans, Male, Muscular Atrophy
- Abstract
The bed rest (BR) is a ground-based model to simulate microgravity mimicking skeletal-muscle alterations as in spaceflight. Molecular coupling between bone and muscle might be involved in physiological and pathological conditions. Thus, the new myokine irisin and bone-muscle turnover markers have been studied during and after 10 days of BR. Ten young male individuals were subjected to 10 days of horizontal BR. Serum concentrations of irisin, myostatin, sclerostin, and haptoglobin were assessed, and muscle tissue gene expression on vastus lateralis biopsies was determined. During 10-days BR, we observed no significant fluctuation levels of irisin, myostatin, and sclerostin. Two days after BR (R+2), irisin serum levels significantly decreased while myostatin, sclerostin, and haptoglobin were significantly increased compared with BR0. Gene expression of myokines, inflammatory molecules, transcription factors, and markers of muscle atrophy and senescence on muscle biopsies were not altered, suggesting that muscle metabolism of young, healthy subjects is able to adapt to the hypomobility condition during 10-day BR. However, when subjects were divided according to irisin serum levels at BR9, muscle ring finger-1 mRNA expression was significantly lower in subjects with higher irisin serum levels, suggesting that this myokine may prevent the triggering of muscle atrophy. Moreover, the negative correlation between p21 mRNA and irisin at BR9 indicated a possible inhibitory effect of the myokine on the senescence marker. In conclusion, irisin could be a prognostic marker of hypomobility-induced muscle atrophy, and its serum levels could protect against muscle deterioration by preventing and/or delaying the expression of atrophy and senescence cellular markers., (© 2022 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.)
- Published
- 2023
- Full Text
- View/download PDF
42. Antidepressant Effect of Intermittent Long-Term Systemic Administration of Irisin in Mice.
- Author
-
Pignataro P, Dicarlo M, Zerlotin R, Storlino G, Oranger A, Sanesi L, Lovero R, Buccoliero C, Mori G, Colaianni G, Colucci S, and Grano M
- Subjects
- Animals, Brain-Derived Neurotrophic Factor metabolism, Cytokines, Disease Models, Animal, Hindlimb Suspension, Mice, Swimming, Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Depression drug therapy, Fibronectins genetics, Fibronectins pharmacology, Fibronectins therapeutic use
- Abstract
Depression is a psychiatric disorder increasingly diffused worldwide. Evidence suggests that irisin, a myokine secreted by contracting muscle, mediates beneficial effects on several targets, including the brain. Here, the potential antidepressant properties of long-term intermittent systemic irisin administration (100 µg/kg/weekly for 1 month) were evaluated in mice by the Tail Suspension Test (TST), Forced Swim Test (FST), and Open Field Test (OFT). Furthermore, to deepen the molecular pathways underlying irisin treatment, the expression of irisin precursor, neurotrophic/growth factors, and cytokines was analyzed. Irisin treatment significantly decreased the immobility time in the TST and FST, suggesting an antidepressant effect. Additionally, irisin seemed to display an anxiolytic-like effect increasing the time spent in the OFT arena center. These findings were probably due to the modulation of endogenous brain factors as the gene expression of some neurotrophins, such as brain-derived neurotrophic factor (BDNF) and insulin-like growth factor (IGF-1), was upregulated only in irisin-treated mouse brain. Moreover, irisin modulated the expression of some cytokines (IL-1β, IL-4, IL-6, and IL-10). To the best of our knowledge, this is the first study demonstrating that the irisin antidepressant effect may be observed even with a systemic administration in mice. This could pave the way toward intriguing preclinical research in humans.
- Published
- 2022
- Full Text
- View/download PDF
43. Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients.
- Author
-
Colaianni G, Oranger A, Dicarlo M, Lovero R, Storlino G, Pignataro P, Fontana A, Di Serio F, Ingravallo A, Caputo G, Di Leo A, Barone M, and Grano M
- Subjects
- Biomarkers, Cohort Studies, Female, Humans, Male, Muscle, Skeletal, Charcot-Marie-Tooth Disease diagnosis, Fibronectins blood, Hand Strength, Muscular Atrophy etiology
- Abstract
Background: Charcot-Marie-Tooth (CMT) indicates a group of inherited polyneuropathies whose clinical phenotypes primarily include progressive distal weakness and muscle atrophy. Compelling evidence showed that the exercise-mimetic myokine irisin protects against muscle wasting in an autocrine manner, thus possibly preventing the onset of musculoskeletal atrophy. Therefore, we sought to determine if irisin serum levels correlate with biochemical and muscle parameters in a cohort of CMT patients., Methods: This cohort study included individuals (N=20) diagnosed with CMT disease. Irisin and biochemical markers were quantified in sera. Skeletal muscle mass (SMM) was evaluated by bioelectric impedance analysis, muscle strength by handgrip, and muscle quality was derived from muscle strength and muscle mass ratio., Results: CMT patients (m/f, 12/8) had lower irisin levels than age and sex matched healthy subjects (N=20) (6.51 ± 2.26 vs 9.34 ± 3.23 μg/ml; p=0.003). SMM in CMT patients was always lower compared to SMM reference values reported in healthy Caucasian population matched for age and sex. Almost the totality of CMT patients (19/20) showed low muscle quality and therefore patients were evaluated on the basis of muscle strength. Irisin was lower in presence of pathological compared to normal muscle strength (5.56 ± 1.26 vs 7.67 ± 2.72 μg/ml; p=0.03), and directly correlated with the marker of bone formation P1PN (r= 0.669; 95%CI 0.295 to 0.865; p=0.002), but inversely correlated with Vitamin D (r=-0.526; 95%CI -0,791 to -0,095; p=0.017). Surprisingly, in women, irisin levels were higher than in men (7.31 ± 2.53 vs 5.31 ± 1.02 μg/ml, p=0.05), and correlated with both muscle strength (r=0.759; 95%CI 0.329 to 0.929; p=0.004) and muscle quality (r=0.797; 95%CI 0.337 to 0.950; p=0.006)., Conclusion: Our data demonstrate lower irisin levels in CMT patients compared to healthy subjects. Moreover, among patients, we observed, significantly higher irisin levels in women than in men, despite the higher SMM in the latter. Future studies are necessary to establish whether, in this clinical contest, irisin could represent a marker of the loss of muscle mass and strength and/or bone loss., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Colaianni, Oranger, Dicarlo, Lovero, Storlino, Pignataro, Fontana, Di Serio, Ingravallo, Caputo, Di Leo, Barone and Grano.)
- Published
- 2022
- Full Text
- View/download PDF
44. Irisin and Secondary Osteoporosis in Humans.
- Author
-
Zerlotin R, Oranger A, Pignataro P, Dicarlo M, Maselli F, Mori G, Colucci SC, Grano M, and Colaianni G
- Subjects
- Humans, Models, Biological, Recombinant Proteins pharmacology, Fibronectins metabolism, Osteoporosis pathology
- Abstract
Irisin is a peptide secreted by skeletal muscle following exercise that plays an important role in bone metabolism. Numerous experiments in vitro and in mouse models have shown that the administration of recombinant irisin promotes osteogenesis, protects osteocytes from dexamethasone-induced apoptosis, prevents disuse-induced loss of bone and muscle mass, and accelerates fracture healing. Although some aspects still need to be elucidated, such as the dose- and frequency-dependent effects of irisin in cell cultures and mouse models, ample clinical evidence is emerging to support its physiological relevance on bone in humans. A reduction in serum irisin levels, associated with an increased risk of osteoporosis and bone fractures, was observed in postmenopausal women and in both men and women during aging, Recently, cohort studies of subjects with secondary osteoporosis showed that these patients have lower circulating levels of irisin, suggesting that this myokine could be a novel marker to monitor bone quality in this disease. Although there are still few studies, this review discusses the emerging data that are highlighting the involvement of irisin in some diseases that cause secondary osteoporosis.
- Published
- 2022
- Full Text
- View/download PDF
45. Systemic Administration of Recombinant Irisin Accelerates Fracture Healing in Mice.
- Author
-
Colucci SC, Buccoliero C, Sanesi L, Errede M, Colaianni G, Annese T, Khan MP, Zerlotin R, Dicarlo M, Schipani E, Kozloff KM, and Grano M
- Subjects
- Animals, Cartilage metabolism, Male, Mice, Mice, Inbred C57BL, Osteoclasts metabolism, Cartilage cytology, Fibronectins administration & dosage, Fracture Healing, Fractures, Bone therapy, Osteoclasts cytology, Osteogenesis, Recombinant Proteins administration & dosage
- Abstract
To date, pharmacological strategies designed to accelerate bone fracture healing are lacking. We subjected 8-week-old C57BL/6 male mice to closed, transverse, mid-diaphyseal tibial fractures and treated them with intraperitoneal injection of a vehicle or r-irisin (100 µg/kg/weekly) immediately following fracture for 10 days or 28 days. Histological analysis of the cartilaginous callus at 10 days showed a threefold increase in Collagen Type X ( p = 0.0012) and a reduced content of proteoglycans (40%; p = 0.0018). Osteoclast count within the callus showed a 2.4-fold increase compared with untreated mice ( p = 0.026), indicating a more advanced stage of endochondral ossification of the callus during the early stage of fracture repair. Further evidence that irisin induced the transition of cartilage callus into bony callus was provided by a twofold reduction in the expression of SOX9 ( p = 0.0058) and a 2.2-fold increase in RUNX2 ( p = 0.0137). Twenty-eight days post-fracture, microCT analyses showed that total callus volume and bone volume were increased by 68% ( p = 0.0003) and 67% ( p = 0.0093), respectively, and bone mineral content was 74% higher ( p = 0.0012) in irisin-treated mice than in controls. Our findings suggest that irisin promotes bone formation in the bony callus and accelerates the fracture repair process, suggesting a possible use as a novel pharmacologic modulator of fracture healing.
- Published
- 2021
- Full Text
- View/download PDF
46. In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts.
- Author
-
Colaianni G, Errede M, Sanesi L, Notarnicola A, Celi M, Zerlotin R, Storlino G, Pignataro P, Oranger A, Pesce V, Tarantino U, Moretti B, and Grano M
- Subjects
- Humans, Osteoblasts, Osteoporosis
- Published
- 2021
- Full Text
- View/download PDF
47. The Novel Role of PGC1α in Bone Metabolism.
- Author
-
Buccoliero C, Dicarlo M, Pignataro P, Gaccione F, Colucci S, Colaianni G, and Grano M
- Subjects
- Animals, Bone and Bones physiology, Cell Differentiation genetics, Humans, Mice, Mitochondria metabolism, Organelle Biogenesis, Osteoblasts metabolism, Osteocytes metabolism, Osteogenesis, Signal Transduction, Sirtuin 3 metabolism, Transcription Factors metabolism, Bone and Bones metabolism, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha metabolism, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha physiology
- Abstract
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) is a protein that promotes transcription of numerous genes, particularly those responsible for the regulation of mitochondrial biogenesis. Evidence for a key role of PGC1α in bone metabolism is very recent. In vivo studies showed that PGC1α deletion negatively affects cortical thickness, trabecular organization and resistance to flexion, resulting in increased risk of fracture. Furthermore, in a mouse model of bone disease, PGC1α activation stimulates osteoblastic gene expression and inhibits atrogene transcription. PGC1α overexpression positively affects the activity of Sirtuin 3, a mitochondrial nicotinammide adenina dinucleotide (NAD)-dependent deacetylase, on osteoblastic differentiation. In vitro , PGC1α overexpression prevents the reduction of mitochondrial density, membrane potential and alkaline phosphatase activity caused by Sirtuin 3 knockdown in osteoblasts. Moreover, PGC1α influences the commitment of skeletal stem cells towards an osteogenic lineage, while negatively affects marrow adipose tissue accumulation. In this review, we will focus on recent findings about PGC1α action on bone metabolism, in vivo and in vitro , and in pathologies that cause bone loss, such as osteoporosis and type 2 diabetes.
- Published
- 2021
- Full Text
- View/download PDF
48. The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs.
- Author
-
Posa F, Colaianni G, Di Cosola M, Dicarlo M, Gaccione F, Colucci S, Grano M, and Mori G
- Abstract
The myokine irisin, well known for its anabolic effect on bone tissue, has been demonstrated to positively act on osteoblastic differentiation processes in vitro. Mesenchymal stem cells (MSCs) have captured great attention in precision medicine and translational research for several decades due to their differentiation capacity, potent immunomodulatory properties, and their ability to be easily cultured and manipulated. Dental bud stem cells (DBSCs) are MSCs, isolated from dental tissues, that can effectively undergo osteoblastic differentiation. In this study, we analyzed, for the first time, the effects of irisin on DBSC osteogenic differentiation in vitro. Our results indicated that DBSCs were responsive to irisin, showed an enhanced expression of osteocalcin (OCN), a late marker of osteoblast differentiation, and displayed a greater mineral matrix deposition. These findings lead to deepening the mechanism of action of this promising molecule, as part of osteoblastogenesis process. Considering the in vivo studies of the effects of irisin on skeleton, irisin could improve bone tissue metabolism in MSC regenerative procedures.
- Published
- 2021
- Full Text
- View/download PDF
49. The effect of Irisin on bone cells in vivo and in vitro.
- Author
-
Buccoliero C, Oranger A, Colaianni G, Pignataro P, Zerlotin R, Lovero R, Errede M, and Grano M
- Subjects
- Animals, Bone Density drug effects, Bone Diseases, Metabolic etiology, Bone Diseases, Metabolic metabolism, Bone Diseases, Metabolic pathology, Bone and Bones cytology, Cell Differentiation drug effects, Child, Female, Fibronectins metabolism, Fibronectins physiology, Humans, Middle Aged, Osteocytes cytology, Osteocytes drug effects, Osteocytes physiology, Bone and Bones drug effects, Fibronectins pharmacology
- Abstract
The myokine Irisin, produced during physical exercise, has an anabolic effect on bone, both in vitro and in vivo. Very recently, using a controlled in vitro 3D cell model to mimic the bone microenvironment aboard the International Space Station, it has been shown that Irisin treatment in microgravity prevents the down-regulation of the transcription factors Atf4, Runx2 and Osterix, as well as Collagen I and Osteoprotegerin proteins, crucial for osteoblast differentiation in physiologic conditions. Irisin action has also been investigated in human subjects, in which it correlates with bone health status, supporting its physiological importance also in human bone, both in healthy subjects and in patients suffering from diseases related to bone metabolism, such as hyperparathyroidism and type 1 diabetes. Low levels of circulating Irisin have been found in post-menopausal women affected by hyperparathyroidism. Furthermore, Irisin is positively correlated with bone strength in athletes and bone mineral density in football players. Moreover, in healthy children, Irisin is positively associated with bone mineral status and in children with type 1 diabetes, Irisin is positively correlated with improved glycemic control and skeletal health. In this review, we will focus on recent findings about Irisin action on microgravity induced bone loss and on osteocyte activity and survival through its αV/β5 integrin receptor., (© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.)
- Published
- 2021
- Full Text
- View/download PDF
50. Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts.
- Author
-
Colaianni G, Errede M, Sanesi L, Notarnicola A, Celi M, Zerlotin R, Storlino G, Pignataro P, Oranger A, Pesce V, Tarantino U, Moretti B, and Grano M
- Subjects
- Aged, Animals, Cyclin-Dependent Kinase Inhibitor p21, Femur Neck, Humans, Mice, Muscular Atrophy, Osteoblasts, Bone Density, Fibronectins genetics
- Abstract
Irisin is a myokine produced by skeletal muscle during exercise in both mice and humans. We previously showed that irisin treatment ameliorates immobility-induced osteoporosis and muscular atrophy in mice. Data in humans showed a positive association between irisin and bone mineral density (BMD) in athletes and a population of healthy children. However, the role of this myokine regarding the state of muscle and bone in the same population remained to be determined. For this purpose, 62 patients (age 68.71 ± 12.31 years) undergoing total hip or knee replacement were recruited. Our results showed that irisin serum levels negatively correlated with age (R = -0.515; p = .000018) and positively correlated with femoral BMD (R = 0.619; p = .001) and vertebral BMD (R = 0.201; p = .0001). Irisin was also positively associated with Fndc5 mRNA in muscle biopsies (R = 0.248; p = .016), as well as with Osteocalcin (Ocn) mRNA in bone biopsies (R = 0.708; p = .006). In skeletal muscle, FNDC5 positive fibers positively correlate with BMD of total femur (R = 0.765; p = .0014) and BMD of femoral neck (R = 0.575; p = .031), Interestingly, by analyzing patients divided by their T-score, we found lower irisin levels (p = .0011) in patients with osteopenia/osteoporosis (OP) compared to healthy controls matched for age and sex. By analyzing the senescence marker p21, we found a significant increase of its mRNA expression in the bone biopsies of OP patients compared to control ones. Therefore, we investigated in vitro whether rec-irisin had a direct effect on this senescence marker, showing that p21 mRNA expression was significantly downregulated in osteoblasts by the treatment with irisin. Overall, these results indicate that higher irisin levels are associated with a lower rate of age-related osteoporosis and that irisin could be effective in delaying the osteoblast aging process, suggesting a potential senolytic action of this myokine. © 2020 American Society for Bone and Mineral Research (ASBMR)., (© 2020 American Society for Bone and Mineral Research (ASBMR).)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.